Disturbances of Basal and Postprandial Insulin Secretion and Clearance in Obese Patients with Type 2 Diabetes Mellitus

 

 Buy Article Permissions and Reprints

Abstract

Hyperinsulinemia of nondiabetic overweight and obese subjects is associated with weight-dependent increased insulin secretion and decreased insulin clearance. The present analysis examines whether similar effects can be observed in overweight and obese patients with type 2 diabetes mellitus (DM2). Additionally basal and postprandial insulin secretion and clearance were analyzed in relation to duration of disease. In a random sample of 348 DM2 patients basal plasma insulin concentrations were significantly higher in most BMI groups compared to matched nondiabetic (ND) controls. The weight-dependent increase of basal insulin in DM2 was primarily the result of reduced clearance rather than augmented secretion. Postprandial insulin concentrations were lower in DM2 patients and did not show any BMI-related increase. The weight-dependent reduction of postprandial insulin clearance was absent in DM2. At the time of diagnosis basal insulin concentration was higher and secretion was comparable to ND subjects and this did not change with duration of diabetes. The early postprandial insulin response was still comparable between DM2 and ND subjects at the time of diagnosis but deteriorated with longer duration of disease. The later postprandial response at diagnosis (AUC 90–180) was characterized by significantly greater insulin secretion and concentration while later on the 3-fold higher secretion was paralleled by comparable peripheral plasma concentrations due to a significantly greater postprandial insulin clearance in DM2. In conclusion, the present data indicate that apart from disturbances of insulin secretion substantial changes of insulin clearance contribute to inadequate peripheral insulin concentrations in obese DM2 patients.

• References

• 1 Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 1967; 46: 1954-1962
  CrossrefPubMedGoogle Scholar
• 2 Danowski TS, Lombardo YB, Mendelsohn LV, Corredor DG, Morgan CR, Sabeh G. Insulin patterns prior to and after onset of diabetes. Metabolism 1969; 18: 731-740
  CrossrefPubMedGoogle Scholar
• 3 Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960; 39: 1157-1175
  CrossrefPubMedGoogle Scholar
• 4 Karam JH, Grodsky GM, Pavlatos FC, Forsham PH. Critical factors in excessive serum-insulin response to glucose. Obesity in maturity-onset diabetes and growth hormone in acromegaly. Lancet 1965; 1: 286-289
  PubMedGoogle Scholar
• 5 Bagdade JD, Bierman EL, Porte Jr D. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 1967; 46: 1549-1557
  CrossrefPubMedGoogle Scholar
• 6 Chen KW, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Diabetes Care 1995; 18: 747-753
  CrossrefPubMedGoogle Scholar
• 7 Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988; 318: 1217-1225
  CrossrefPubMedGoogle Scholar
• 8 Hovorka R, Chassin L, Luzio SD, Playle R, Owens DR. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 744-750
  CrossrefPubMedGoogle Scholar
• 9 Hovorka R, Albarrak A, Chassin L, Luzio SD, Playle R, Owens DR. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes. Diabet Med 2001; 18: 797-802
  CrossrefPubMedGoogle Scholar
• 10 Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004; 47: 31-39
  CrossrefPubMedGoogle Scholar
• 11 Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 1977; 26: 944-952
  PubMedGoogle Scholar
• 12 Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM. Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 1984; 33: 634-642
  CrossrefPubMedGoogle Scholar
• 13 Savage PJ, Bennion LJ, Flock EV, Nagulesparan M, Mott D, Roth J, Unger RH, Bennett PH. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. J Clin Endocrinol Metab 1979; 48: 999-1007
  CrossrefPubMedGoogle Scholar
• 14 Garvey WT, Olefsky JM, Rubenstein AH, Kolterman OG. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion. Diabetes 1988; 37: 590-599
  CrossrefPubMedGoogle Scholar
• 15 Escalante-Pulido M, Escalante-Herrera A, Milke-Najar ME, Alpizar-Salazar M. Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects. Diabetes Nutr Metab 2003; 16: 277-283
  PubMedGoogle Scholar
• 16 Henry RR, Brechtel G, Griver K. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1988; 66: 979-986
  CrossrefPubMedGoogle Scholar
• 17 DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-368
  CrossrefPubMedGoogle Scholar
• 18 Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 12: 841-845
  PubMedGoogle Scholar
• 19 Goetz FC, Roel J, Jacobs Jr DR, Barbosa J, Hannan P, Palmer J, Hagopian W. Declining β-cell function in type 2 diabetes: 5-year follow-up and immunologic studies of the population of Wadena, MN. Metabolism 2002; 51: 144-148
  CrossrefPubMedGoogle Scholar
• 20 Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-DI. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988; 37: 1020-1024
  CrossrefPubMedGoogle Scholar
• 21 Scarlett JA, Kolterman OG, Ciaraldi TP, Kao M, Olefsky JM. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab 1983; 56: 1195-1201
  CrossrefPubMedGoogle Scholar
• 22 Liu G, Coulston A, Chen YD, Reaven GM. Does day-long absolute hypoinsulinemia characterize the patient with non-insulin-dependent diabetes mellitus?. Metabolism 1983; 32: 754-756
  CrossrefPubMedGoogle Scholar
• 23 Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 2008; 294: E568-E575
  CrossrefPubMedGoogle Scholar
• 24 Erdmann J, Mayr M, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regul Pept 2009; 152: 1-7
  CrossrefPubMedGoogle Scholar
• 25 Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452
  PubMedGoogle Scholar
• 26 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26 (Suppl. 01) S5-S20
  CrossrefPubMedGoogle Scholar
• 27 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 7: 412-419
  PubMedGoogle Scholar
• 28 Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 3: 368-377
  PubMedGoogle Scholar
• 29 Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 1980; 51: 520-528
  CrossrefPubMedGoogle Scholar
• 30 Greenblatt DJ, Kochweser J. Drug therapy: clinical pharmacokinetics. N Engl J Med 1975; 293: 702-705
  CrossrefPubMedGoogle Scholar
• 31 Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1989; 1: 1356-1359
  PubMedGoogle Scholar
• 32 Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 1991; 73: 866-876
  CrossrefPubMedGoogle Scholar
• 33 Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343
  CrossrefPubMedGoogle Scholar
• 34 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
  PubMedGoogle Scholar
• 35 Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 2008; 135: 122-130
  CrossrefPubMedGoogle Scholar
• 36 Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol 1983; 244: E517-E527
  PubMedGoogle Scholar
• 37 Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 2007; 293: E1709-E1715
  CrossrefPubMedGoogle Scholar
• 38 Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 1231-1239
  CrossrefPubMedGoogle Scholar
• 39 Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte Jr D. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976; 42: 222-229
  CrossrefPubMedGoogle Scholar
• 40 Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610-630
  CrossrefPubMedGoogle Scholar
• 41 Vague P, Moulin JP. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Metabolism 1982; 31: 139-142
  CrossrefPubMedGoogle Scholar
• 42 Kosaka K, Kuzuya T, Akanuma Y, Hagura R. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 1980; 18: 23-28
  CrossrefPubMedGoogle Scholar
• 43 Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 2009; 32: 375-380
  CrossrefPubMedGoogle Scholar
• 44 Meyer J, Sturis J, Katschinski M, Arnold R, Goke B, Byrne MM. Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose. Am J Physiol Endocrinol Metab 2002; 282: E917-E922
  PubMedGoogle Scholar